Post Job

Revance Therapeutics Overview

Industry
Pharmaceutical
Revenue
Headquarters
Employees
170
Founded In
1999
Organization Type
Public
Revance Therapeutics, Inc., a biopharmaceutical company, engages in developing and commercializing products and treatments in dermatology and aesthetic medicines. Its products include RT001, a physician-applied topical botulinum toxin type A (BoNT-A) for cosmetic, hyperhidrosis, and dermatologic indications. The company was formerly known as Essentia Biosystems, Inc. Revance Therapeutics, Inc. was founded in 2002 and is based in Mountain View, California.
Founded in 1999, Revance Therapeutics is an established company that loves to hire graduates from University of California, Berkeley, with 18.2% of its employees having attended University of California, Berkeley. Revance Therapeutics has established itself as a great place to work in California, and it is number 17 on Zippia's list of Best Companies to Work for in Newark, CA. The average employee at Revance Therapeutics makes $100,998 per year, which is competitive for its industry and location. Some of its highest paying competitors, Karyopharm, Vertex Pharmaceuticals, and Ariad Pharmaceuticals, pay $107,666, $95,952, and $94,078, respectively.
Revance Therapeutics is a small pharmaceutical company based in California with only 170 employees and an annual revenue of $15.3M.

The Organization’s Mission

Revance is dedicated to making a difference by transforming patient experiences and is positioned to be an innovation leader not only in aesthetics, but also in therapeutics. We believe in leaving bureaucracy behind. We value speed, audacity, grit and empathy, and empower our teams to reimagine the status quo.
-

Employee Reviews

Be the first to review!

Do you work at Revance Therapeutics?

Help us make this company more transparent

Job Openings
18 Positions
Average Salary
$100,998 yearly

On This Page

Be The First To Review Revance Therapeutics

Anonymously rate your employee experience

Your Opinion can Help Other Job Seekers

Do You Like Working At Revance Therapeutics?

The Team At Revance Therapeutics

Key People
Mark J. Foley
Jacob Waugh
L. Daniel Browne

Revance Therapeutics Rankings

Revance Therapeutics is ranked #59 on the Best Pharmaceutical Companies to Work For in California list. Zippia's Best Places to Work lists provide unbiased, data-based evaluations of companies. Rankings are based on government and proprietary data on salaries, company financial health, and employee diversity.

Read more about how we rank companies.

Revance Therapeutics Salaries

9.5
Salary Score
The national average salary for a Revance Therapeutics employee in the United States is $100,998 per year. Employees in the top 10 percent can make over $155,000 per year, while employees at the bottom 10 percent earn less than $65,000 per year.
Average Revance Therapeutics Salary
$100,998
yearly
$48.56 hourly
Updated March 16, 2023

Revance Therapeutics Financial Performance

8.3
Performance Score
We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.

How Would You Rate The Company Culture Of Revance Therapeutics?

Have you worked at Revance Therapeutics? Help other job seekers by rating Revance Therapeutics.

Highest Paying Revance Therapeutics Competitors

Competitors of Revance Therapeutics include Karyopharm, Vertex Pharmaceuticals, and Ariad Pharmaceuticals. The wages at Karyopharm average higher than the other similar companies, where the median salary is $107,666 per year. The salaries at Vertex Pharmaceuticals average $95,952 per year, and the salaries at Ariad Pharmaceuticals come in at $94,078 per year.

Are You An Executive, HR Leader, Or Brand Manager At Revance Therapeutics?

Claiming and updating your company profile on Zippia is free and easy.

Revance Therapeutics FAQs

When Was Revance Therapeutics Founded?

Revance Therapeutics was founded in 1999.

How Many Employees Does Revance Therapeutics Have?

Revance Therapeutics has 170 employees.

How Much Money Does Revance Therapeutics Make?

Revance Therapeutics generates $15.3M in revenue.

What Industry Is Revance Therapeutics In?

Revance Therapeutics is in the pharmaceutical industry.

What Is Revance Therapeutics's Mission?

Revance Therapeutics's mission statement is "Revance is dedicated to making a difference by transforming patient experiences and is positioned to be an innovation leader not only in aesthetics, but also in therapeutics. We believe in leaving bureaucracy behind. We value speed, audacity, grit and empathy, and empower our teams to reimagine the status quo."

What Type Of Company Is Revance Therapeutics?

Revance Therapeutics is a public company.

Who Are Revance Therapeutics's Competitors?

Revance Therapeutics competitors include SIGA Technologies, Nanotherapeutics, Inc., MAP Pharmaceuticals, Acusphere, Nektar Therapeutics, Ariad Pharmaceuticals, Vertex Pharmaceuticals, Hoffmann-LA Roche Inc, Emisphere Technologies, PTC Therapeutics, Karyopharm.

Who Works At Revance Therapeutics?

Mark J. Foley (President/CEO)

Jacob Waugh (Founder)

L. Daniel Browne (Founder)

Search For Jobs

Most Common Locations At Revance Therapeutics

Most Common Jobs At Revance Therapeutics

Zippia gives an in-depth look into the details of Revance Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Revance Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Revance Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Revance Therapeutics. The data presented on this page does not represent the view of Revance Therapeutics and its employees or that of Zippia.

Revance Therapeutics may also be known as or be related to REVANCE THERAPEUTICS INC., Revance Therapeutics, Revance Therapeutics Inc and Revance Therapeutics, Inc.